Suzuki Y, Suzuki K
Science. 1971 Jan 8;171(3966):73-5. doi: 10.1126/science.171.3966.73.
The activity of galactocerebroside beta-galactosidase was extremely low in serum, leukocytes, and cultured fibroblasts of patients with Krabbe's disease. Antemortem diagnosis is possible without organ biopsies. The parents of patients showed enzyme activities generally lower than that of normal controls. This finding provides supportive evidence that the deficient activity of galactocerebroside beta-galactosidase is the genetically determined enzymatic defect underlying the disease. Demonstration of this deficiency requires the use of the specific substrate, galactocerebroside. Assays carried out with synthetic, unnatural substrates, such as 4-methylumbelliferyl beta-galactoside, do not distinguish patients or heterozygous carriers from normal individuals.
在克拉贝病患者的血清、白细胞和培养的成纤维细胞中,半乳糖脑苷脂β - 半乳糖苷酶的活性极低。无需进行器官活检即可进行生前诊断。患者的父母显示出的酶活性通常低于正常对照组。这一发现提供了支持性证据,表明半乳糖脑苷脂β - 半乳糖苷酶活性缺乏是该疾病潜在的遗传决定的酶缺陷。证明这种缺陷需要使用特定的底物半乳糖脑苷脂。用合成的非天然底物,如4 - 甲基伞形酮基β - 半乳糖苷进行的检测,无法区分患者或杂合携带者与正常个体。